168 related articles for article (PubMed ID: 25971525)
1. Validation of Risk Scoring System Excluding Female Sex From CHA2DS2-VASc in Japanese Patients With Nonvalvular Atrial Fibrillation – Subanalysis of the J-RHYTHM Registry.
Tomita H; Okumura K; Inoue H; Atarashi H; Yamashita T; Origasa H; Tsushima E;
Circ J; 2015; 79(8):1719-26. PubMed ID: 25971525
[TBL] [Abstract][Full Text] [Related]
2. Validation of CHA₂DS₂-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM Registry.
Okumura K; Inoue H; Atarashi H; Yamashita T; Tomita H; Origasa H;
Circ J; 2014; 78(7):1593-9. PubMed ID: 24759791
[TBL] [Abstract][Full Text] [Related]
3. Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA
Nielsen PB; Skjøth F; Overvad TF; Larsen TB; Lip GYH
Circulation; 2018 Feb; 137(8):832-840. PubMed ID: 29459469
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of R
Methavigul K; Sairat P; Krittayaphong R;
BMC Cardiovasc Disord; 2021 Nov; 21(1):540. PubMed ID: 34772351
[TBL] [Abstract][Full Text] [Related]
5. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
[TBL] [Abstract][Full Text] [Related]
6. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
Kornej J; Hindricks G; Kosiuk J; Arya A; Sommer P; Husser D; Rolf S; Richter S; Piorkowski C; Gaspar T; Lip GY; Bollmann A
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
[TBL] [Abstract][Full Text] [Related]
7. Validation of the CHA2DS2-VA Score (Excluding Female Sex) in Nonvalvular Atrial Fibrillation Patients: A Nationwide Population-Based Study.
Choi SY; Kim MH; Kim HB; Kang SY; Lee KM; Hyun KY; Yun SC
J Clin Med; 2022 Mar; 11(7):. PubMed ID: 35407433
[TBL] [Abstract][Full Text] [Related]
8. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS
Katz DF; Maddox TM; Turakhia M; Gehi A; O'Brien EC; Lubitz SA; Turchin A; Doros G; Lei L; Varosy P; Marzec L; Hsu JC
Circ Cardiovasc Qual Outcomes; 2017 May; 10(5):. PubMed ID: 28506981
[TBL] [Abstract][Full Text] [Related]
9. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
[TBL] [Abstract][Full Text] [Related]
10. CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation.
Chau KH; Scherzer R; Grunfeld C; Hsue PY; Shlipak MG
J Acquir Immune Defic Syndr; 2017 Sep; 76(1):90-97. PubMed ID: 28797024
[TBL] [Abstract][Full Text] [Related]
11. Effect of hypertrophic cardiomyopathy on the prediction of thromboembolism in patients with nonvalvular atrial fibrillation.
Tsuda T; Hayashi K; Fujino N; Konno T; Tada H; Nomura A; Tanaka Y; Sakata K; Furusho H; Takamura M; Kawashiri MA; Yamagishi M;
Heart Rhythm; 2019 Jun; 16(6):829-837. PubMed ID: 30503962
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of CAS risk model and CHA
Deng JL; He L; Jiang C; Lai YW; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Hu R; Dong JZ; Du X; Tang RB; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep; 50(9):888-894. PubMed ID: 36096706
[No Abstract] [Full Text] [Related]
14. CHA
D'Souza M; Carlson N; Fosbøl E; Lamberts M; Smedegaard L; Nielsen D; Torp-Pedersen C; Gislason G; Schou M
Eur J Prev Cardiol; 2018 Apr; 25(6):651-658. PubMed ID: 29482441
[TBL] [Abstract][Full Text] [Related]
15. Which risk score best predicts perioperative outcomes in nonvalvular atrial fibrillation patients undergoing noncardiac surgery?
van Diepen S; Youngson E; Ezekowitz JA; McAlister FA
Am Heart J; 2014 Jul; 168(1):60-7.e5. PubMed ID: 24952861
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolic events in paroxysmal vs. permanent non-valvular atrial fibrillation. Subanalysis of the J-RHYTHM Registry.
Inoue H; Atarashi H; Okumura K; Yamashita T; Kumagai N; Origasa H
Circ J; 2014; 78(10):2388-93. PubMed ID: 25099606
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score.
Yan S; Li Q; Xia Z; Yan S; Wei Y; Hong K; Wu Y; Li J; Cheng X
Medicine (Baltimore); 2019 Feb; 98(8):e14549. PubMed ID: 30813164
[TBL] [Abstract][Full Text] [Related]
18. Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA
Østergaard L; Olesen JB; Petersen JK; Nielsen LS; Kristensen SL; Schou M; Køber L; Fosbøl E
Circulation; 2024 Mar; 149(10):764-773. PubMed ID: 38152890
[TBL] [Abstract][Full Text] [Related]
19. CHA
Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
Zhu WG; Xiong QM; Hong K
Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
